Journal article
HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression
Alberto Pugliese, David Boulware, Liping Yu, Sunanda Babu, Andrea K Steck, Dorothy Becker, Henry Rodriguez, Linda DiMeglio, Carmella Evans-Molina, Leonard C Harrison, Desmond Schatz, Jerry P Palmer, Carla Greenbaum, George S Eisenbarth, Jay M Sosenko
Diabetes | AMER DIABETES ASSOC | Published : 2016
DOI: 10.2337/db15-1105
Grants
Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development
Funding Acknowledgements
The sponsor of the trial was the Type 1 Diabetes TrialNet Pathway to Prevention Study Group. Type 1 Diabetes TrialNet Pathway to Prevention Study Group is a clinical trials network funded by the National Institutes of Health_(NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development through the cooperative agreements U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085465, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085504, U01 DK085505, U01 DK085509, U01 DK103180, U01 DK103153, U01 DK085476, and U01 DK103266. The study group is also funded by JDRF.